Clinical Cardiology, Geriatric Cardiology, Heart Failure, and Transplantation 2015: A Selection of Topical Issues;Selección de temas de actualidad en cardiología clínica, cardiología geriátrica e insuficiencia cardiaca y trasplante 2015

Revista Espanola de Cardiologia

Volumn 69, Issue 2, 2016, Pages 159-166

  Martínez Sellés, Manuel ^a   Lambert Rodríguez, José Luis ^b   Barrios, Vivencio ^c   Díez Villanueva, Pablo ^d   García Pinilla, José Manuel ^e   Cosín, Juan ^f   Ariza Solé, Albert ^g   Mirabet Pérez, Sònia ^h   Escobar, Carlos ⁱ   Díaz Castro, Óscar ^j   Segovia Cubero, Javier ^k   Rodríguez, José Ángel ^l  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^b HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^c HOSPITAL RAMÓN Y CAJAL   (Spain)

^d HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^e HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

^f HOSPITAL ARNAU DE VILANOVA   (Spain)

^g HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^h HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

ⁱ HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^j Hospital de Pontevedra   (Spain)

^k HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^l HOSPITAL JUAN CANALEJO   (Spain)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CARDIOLOGY; CLINICAL CARDIOLOGY; GERIATRIC CARDIOLOGY; HEART FAILURE; HEART TRANSPLANTATION; HUMAN; ADULT; AGE; AGED; ATRIAL FIBRILLATION; COMPLICATION; FEMALE; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; SLEEP DISORDERED BREATHING; STROKE; TRENDS; VERY ELDERLY;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; CARDIOLOGY; FEMALE; HEART FAILURE; HEART TRANSPLANTATION; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; SLEEP APNEA, OBSTRUCTIVE; STROKE;

EID: 84958933325     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1016/j.recesp.2015.10.015     Document Type: Article

References (67)

1. G.Y. Lip, F. Skjøth, L.H. Rasmussen, and T.B. Larsen Oral anticoagulation, aspirin, or no therapy in patients with nonvalvular AF with 0 or 1 stroke risk factor based on the CHA2DS2-VASc score J Am Coll Cardiol. 65 2015 1385 1394
2. A.J. Camm, G.Y. Lip, R. de Caterina, I. Savelieva, D. Atar, S.H. Hohnloser, and et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association Eur Heart J. 33 2012 2719 2747
3. L. Friberg, M. Skeppholm, and A. Terént Benefit of anticoagulation unlikely in patients with atrial fibrillation and a CHA2DS2-VASc score of 1 J Am Coll Cardiol. 65 2015 225 232
4. V. Barrios, C. Escobar, L. Prieto, G. Osorio, J. Polo, J.M. Lobos, and et al. Control de la anticoagulación en pacientes con fibrilación auricular no valvular asistidos en atención primaria en España. Estudio PAULA Rev Esp Cardiol. 2015 Jul 11 [Epub ahead of print]
5. F.W. Verheugt, and C.B. Granger Oral anticoagulants for stroke prevention in atrial fibrillation: current status, special situations, and unmet needs Lancet. 386 2015 303 310
6. 2013 ESC guidelines on the management of stable coronary artery disease. The Task Force on the management of stable coronary artery disease of the European Society of Cardiology Eur Heart J. 34 2013 2949 3003
7. Guía de práctica clínica de la ESC 2013 sobre diagnóstico y tratamiento de la cardiopatía isquémica estable Rev Esp Cardiol. 67 2014 135.e1-e81
8. The SCOT-HEART investigators CT coronary angiography in patients with suspected angina due to coronary heart disease (SCOT-HEART): an open-label, parallel-group, multicentre trial Lancet 385 2015 2383 2391
9. D. Linz, H. Woehrle, T. Bitter, H. Fox, M.R. Cowie, M. Böhm, and et al. The importance of sleep-disordered breathing in cardiovascular disease Clin Res Cardiol. 104 2015 705 718
10. P. Lloberes, J. Durán-Cantolla, M.A. Martínez-García, J.M. Marín, A. Ferrer, and J. Corral Normativa SEPAR. Diagnóstico y tratamiento del síndrome de apneas-hipopneas del sueño Arch Bronconeumol 47 2011 143 156
11. P. Defaye, I. de la Cruz, J. Martí Almor, R. Villuendas, P. Bru, J. Sénechal, and et al. A pacemaker transthoracic impedance sensor with an advanced algorithm to identify severe: The DREAM European study Heart Rhythm. 2014 842 848
12. R.C. Basner Cardiovascular morbidity and obstructive sleep apnea N Engl J Med. 370 2014 2339 2341
13. D.J. Gottlieb, N.M. Punjabi, R. Mehra, S.R. Patel, S.F. Quan, D.C. Babineau, and et al. CPAP versus oxygen in obstructive sleep apnea N Engl J Med. 370 2014 2276 2285
14. J.A. Chirinos, I. Gurubhagavatula, K. Teff, D.J. Rader, T.A. Wadden, R. Townsend, and et al. CPAP, weight loss, or both for obstructive sleep apnea N Engl J Med. 370 2014 2265 2275
15. Y.K. Iwasaki, T. Kato, F. Xiong, Y.F. Shi, P. Naud, A. Maguy, and et al. Atrial fibrillation promotion with long-term repetitive obstructive sleep apnea in a rat model J Am Coll Cardiol. 64 2014 2013 2023
16. F. Holmqvist, N. Guan, Z. Zhu, P.R. Kowey, L.A. Allen, G.C. Fonarow, et al. ORBIT-AF Investigators Impact of obstructive sleep apnea and continuous positive airway pressure therapy on outcomes in patients with atrial fibrillation - Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) Am Heart J. 169 2015 647 654
17. D.M. Yaranov, A. Smyrlis, N. Usatii, A. Butler, J.R. Petrini, J. Mendez, and et al. Effect of obstructive sleep apnea on frequency of stroke in patients with atrial fibrillation Am J Cardiol. 115 2015 461 465
18. L. Li, Z.W. Wang, J. Li, X. Ge, L.Z. Guo, Y. Wang, and et al. Efficacy of catheter ablation of atrial fibrillation in patients with obstructive sleep apnoea with and without continuous positive airway pressure treatment: a meta-analysis of observational studies Europace. 16 2014 1309 1314
19. G.A. Roth, M.H. Forouzanfar, A.E. Moran, R. Barber, and G. Nguyen Demographicand epidemiologic drivers of global cardiovascular mortality N Engl J Med. 372 2015 1333 1341
20. G. Sergi, N. Veronese, L. Fontana, M. de Rui, F. Bolzetta, S. Zambon, and et al. Pre-frailty and risk of cardiovascular disease in elderly men and women: the Pro.V.A. study J Am Coll Cardiol. 65 2015 976 983
21. M. Martínez-Sellés, B. García de la Villa, A.J. Cruz-Jentoft, M.T. Vidán, P. Gil, L. Cornide, and et al. Centenarians and their hearts: A prospective registry with comprehensive geriatric assessment, electrocardiogram, echocardiography, and follow-up Am Heart J. 169 2015 798-805.e2
22. M. Martínez-Sellés, B. García de la Villa, A.J. Cruz-Jentoft, M.T. Vidán, M. Ramos Cortés, J.L. González Guerrero, and et al. Sex-related differences in centenarians and their hearts J Am Geriatr Soc. 2015 [en prensa]
23. M. Sharma, V.R. Cornelius, J.P. Patel, J.G. Davies, and M. Molokhia Efficacy and harms of direct oral anticoagulants in the elderly for stroke prevention in atrial fibrillation and secondary prevention of venous thromboembolism: systematic review and meta-analysis Circulation. 2015 May 20 [Epub ahead of print]
24. P.B. Nielsen, T.B. Larsen, F. Skjøth, A. Gorst-Rasmussen, L.A. Rasmussen, and G.Y.H. Lip Restarting anticoagulant treatment after intracranial haemorrhage in patients with atrial fibrillation and the impact on recurrent stroke, mortality and bleeding: a nationwide cohort study Circulation. 2015 June 9 [Epub ahead of print]
25. D. Kotecha, J. Holmes, H. Krum, D.G. Altman, L. Manzano, J.G. Cleland, and et al. Efficacy of β blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis Lancet. 384 2014 2235 2243
26. M. Metra, G. Cotter, J. El-Khorazaty, B.A. Davison, O. Milo, V. Carubelli, and et al. Acute heart failure in the elderly: differences in clinical characteristics, outcomes, and prognostic factors in the VERITAS Study J Card Fail. 21 2015 179 188
27. M. Metra, R.J. Mentz, K. Chiswell, D.M. Bloomfield, J.G. Cleland, G. Cotter, and et al. Acute heart failure in elderly patients: worse outcomes and differential utility of standard prognostic variables. Insights from the PROTECT trial Eur J Heart Fail. 17 2015 109 118
28. K. Krueger, L. Botermann, S.G. Schorr, N. Griese-Mammen, U. Laufs, and M. Schulz Age-related medication adherence in patients with chronic heart failure: A systematic literature review Int J Cardiol. 184 2015 728 735
29. S.B. Barywani, C. Ergatoudes, M. Schaufelberger, M. Petzold, and M.L. Fu Does the target dose of neurohormonal blockade matter for outcome in systolic heart failure in octogenarians? Int J Cardiol. 187 2015 666 672
30. M. Martínez-Sellés, P. Díez-Villanueva, D. Sánchez-Sendin, A. Carro Hevia, J.J. Gómez Doblas, B. García de la Villa, and et al. Comorbidity and intervention in octogenarians with severe symptomatic aortic stenosis Int J Cardiol. 189 2015 61 66
31. M. Martínez-Sellés, J.J. Gómez Doblas, A. Carro Hevia, B. García de la Villa, I. Ferreira-González, A. Alonso Tello, et al. PEGASO Registry Group Prospective registry of symptomatic severe aortic stenosis in octogenarians: a need for intervention J Intern Med. 275 2014 608 620
32. M. Urena, J.G. Webb, H. Eltchaninoff, A.J. Muñoz-García, C. Bouleti, C. Tamburino, and et al. Late cardiac death in patients undergoing transcatheter aortic valve replacement: incidence and predictors of advanced heart failure and sudden cardiac death J Am Coll Cardiol. 65 2015 437 448
33. M. Martínez-Sellés, E. Bouza, P. Díez-Villanueva, M. Valerio, M.C. Fariñas, A.J. Muñoz-García, and et al. Incidence and clinical impact of infective endocarditis after transcatheter aortic valve implantation EuroIntervention. 2015 Feb 12 10.4244/EIJY15M02-05 10 [Epub ahead of print]. pii: 20140826-07.
34. G. Galasso, S. de Servi, S. Savonitto, T. Strisciuglio, R. Piccolo, N. Morici, and et al. Effect of an invasive strategy on outcome in patients >75 years of age with non-ST-elevation acute coronary syndrome Am J Cardiol. 115 2015 576 580
35. F. Angeli, C. Cavallini, P. Verdecchia, N. Morici, M. del Pinto, A.S. Petronio, and et al. A risk score for predicting 1-year mortality in patients 75 years of age presenting with non-ST-elevation acute coronary syndrome Am J Cardiol. 116 2015 208 213
36. H.S. Lim, N. Andrianopoulos, H. Sugumar, D. Stub, A.L. Brennan, C.C. Lim, and et al. Long-term survival of elderly patients undergoing percutaneous coronary intervention for myocardial infarction complicated by cardiogenic shock Int J Cardiol. 195 2015 259 264
37. H.D. White, C.M. Westerhout, K.P. Alexander, M.T. Roe, K.J. Winters, D.D. Cyr, et al. TRILOGY ACS investigators Frailty is associated with worse outcomes in non-ST-segment elevation acute coronary syndromes: Insights from the TaRgeted platelet Inhibition to cLarify the OptimalstrateGy to medicallY manage Acute Coronary Syndromes (TRILOGY ACS) trial Eur Heart J Acute Cardiovasc Care. 2015 Apr 20 [Epub ahead of print]. pii: 2048872615581502
38. P.S. Jhund, M. Fu, E. Bayram, C.H. Chen, M. Negrusz-Kawecka, A. Rosenthal, and et al. Efficacy and safety of LCZ696 (sacubitril-valsartan) according to age: insights from PARADIGM-HF Eur Heart J. 2015 Jul 31 10.1093/eurheartj/ehv330 [Epub ahead of print]
39. A.S. Desai, J.J.V. McMurray, M. PAcker, K. Swedberg, J.L. Rouleau, F. Chen, and et al. Effect of angiotensin-receptor-neprilysin inhibitor LCZ696 compared with enalapril on mode of death in heart failure patients Eur Heart J. 36 2015 1990 1997
40. M. Crespo Leiro, J. Segovia Cubero, J. Gonzalez Costello, A. Bayes-Genis, S. López-Fernández, E. Roig, and et al. Adecuación en España de las recomendaciones terapéuticas de la guía de la ESC sobre insuficiencia cardiaca: ESC Heart Failure Long-term Registry Rev Esp Cardiol. 68 2015 785 793
41. P. Ponikowski, D.J. Van Veldhuisen, J. Comin Colet, G. Ertl, M. Komajda, V. Mareev, et al. CONFIRM-HF Investigators Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency Eur Heart J. 36 2015 657 668
42. D. Kotecha, J. Holmes, H. Krum, D.G. Altman, L. Manzano, J.G. Cleland, et al. Beta-Blockers in Heart Failure Collaborative Group Efficacy of β blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis Lancet. 384 2014 2235 2243
43. J.J.V. Mc Murray, and D.J. Van Velhuisen β blockers, atrial fibrillation, and heart failure Lancet. 384 2014 2181 2183
44. M. Böhm Effect of implanted device-based impedance monitoring with telemedicine alerts on mortality in heart failure (OPTILINK-HF) ESC Congress 2015. HF-Hot line presentation London, UK September 2015 Disponible en: http://congress365.escardio.org/Search-Results?vgnextkeyword=C365PRESENTATION124551#.VgpBntLtlHw
45. M.R. Cowie, H. Woehrle, K. Wegscheider, C. Angermann, M.P. d'Ortho, E. Erdmann, and et al. Adaptative servo-ventilation for central sleep apnea in systolic heart failure N Eng J Med. 373 2015 1095 1105 10.1056/NEJMoa1506459
46. C.A. Morillo, J.A. Martin Nieto, A. Avezum, S. Sosa-Estani, A. Rassi Jr., F. Rosas, and et al. Randomized trial of benznidazole for chronic Chagas cardiomyopathy N Engl J Med. 2015 Sep 1 10.1056/NEJMoa1507574 [Epub ahead of print]
47. B. Greenberg CUPID 2: A phase 2 b trial investigating the efficacy and safety of the intracoronary administration of AAV1/SERCA2a in patients with advanced heart failure ESC Congress 2015. HF-Hot line presentation London, UK September 2015 Disponible en: http://www.escardio.org/static-file/Escardio/Press-media/Press%20releases/2015/Congress/CUPID-Greenberg.pdf
48. J. Comín-Colet Multicenter, double-blind, randomized, placebo-controlled trial evaluating the efficacy and safety of intermittent levosimendan in outpatients with advanced chronic heart failure: the LION Heart Study Late Breaking Trials II: Heart Failure Management/Heart FAILURE 2015 Congress of the ESC-HFA Sevilla 24 de mayo de 2015 Disponible en: http://spo.escardio.org/SessionDetails.aspx?eevtid=1077&sessId=14858#.VWatraM3ups
49. S.D. Anker, P. Ponikowski, V. Mitrovic, W.F. Peacock, and G. Filippatos Ularitide for the treatment of acute decompensated heart failure: from preclinical to clinical studies Eur Heart J. 36 2015 715 723
50. A. Mebazaa, M.B. Yilmaz, P. Levy, P. Ponikowski, W.F. Peacock, S. Laribi, and et al. Recommendations on pre-hospital and early hospital management of acute heart failure: a consensus paper from the Heart Failure Association of the European Society of Cardiology, the European Society of Emergency Medicine and the Society of Academic Emergency Medicine - short version Eur Heart J. 36 2015 1958 1966
51. P.M. Elliott, A. Anastasakis, M.A. Borger, M. Borggrefe, F. Cecchi, P. Charron, and et al. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC) Eur Heart J. 35 2014 2733 2779
52. Grupo de Trabajo de la SEC para la guía de la ESC 2014 sobre el diagnóstico y manejo de la miocardiopatía hipertrófica, revisores expertos para la guía de la ESC 2014 sobre el diagnóstico y manejo de la miocardiopatía hipertrófica, Comité de Guías de la SEC Comentarios a la guía de práctica clínica de la ESC 2014 sobre el diagnóstico y manejo de la miocardiopatía hipertrófica. Una vision crítica desde la cardiología española Rev Esp Cardiol. 68 2015 4 9
53. C. Templin, J.R. Ghadri, J. Diekmann, L.C. Napp, D.R. Bataiosu, M. Jaguszewski, and et al. Clinical features and outcomes of takotsubo (stress) cardiomyopathy N Engl J Med. 373 2015 929 938
54. G. Guzzo-Merello, J. Segovia, F. Dominguez, M. Cobo-Marcos, M. Gomez-Bueno, P. Avellana, and et al. Natural history and prognostic factors in alcoholic cardiomyopathy JACC Heart Fail. 3 2015 78 86
55. J. Haas, K.S. Frese, B. Peil, W. Kloos, A. Keller, R. Nietsch, and et al. Atlas of the clinical genetics of human dilated cardiomyopathy Eur Heart J. 36 2015 1123 1135
56. J. Rogers, A. Boyles, J. O'Connell, D. Horstmanshof, D. Haas, M. Slaughter, and et al. Risk assessment and comparative effectiveness of left ventricular assist device and medical management in ambulatory heart failure patients: Design and rationale of the ROADMAP clinical trial Am Heart J. 169 2015 205 210
57. J.D. Estep, R.C. Starling, D.A. Horstmanshof, J.G. Rogers, C.H. Selzman, K.B. Shah, and et al. Assessment and comparative effectiveness of left ventricular assit device and medical management in ambulatory heart failure patients (ROADMAP). ISHLT 2015 Scientific Sessions April 17, 2015 Disponible en: http://www.jhltonline.org/article/S1053-2498(15)00238-7/Abstract
58. M. Gold, C. Daubert, W. Abraham, S. Ghio, M.J. Sutton, J.H. Hudnall, and et al. The effect of reverse remodeling on long-term survival in mildly symptomatic patients with heart failure receiving cardiac resynchronization therapy: Results of the REVERSE study Heart Rhythm. 12 2015 524 530
59. M. Ruwald, S. Slomon, E. Foster, V. Kutyifa, A.C. Ruwals, S. Sherazi, and et al. Left Ventricular ejection fraction normalization in cardiac resynchronization therapy and risk of ventricular arrhythmias and clinical outcomes. Results from the Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy (MADIT-CRT) Trial Circulation. 130 2014 2278 2286
60. R.D. Yusen, L.B. Edwards, A.Y. Kucheryavaya, C. Benden, A.I. Dipchand, S.B. Goldfarb, and et al. The Registry of the International Society for Heart and Lung Transplantation: Thirty-second Official Adult Lung and Heart-Lung Transplantation Report-2015; focus theme: early graft failure J Heart Lung Transplant. 34 2015 1264 1277
61. F. González-Vílchez, J. Segovia Cubero, L. Almenar, M.G. Crespo-Leiro, J.M. Arizón, and A. Villa Registro Español de Trasplante Cardiaco. XXVI Informe Oficial de la Sección de Insuficiencia Cardiaca y Trasplante Cardiaco de la Sociedad Española de Cardiología (1984-2014) Rev Esp Cardiol. 2015 10.1016/j.recesp.2015.07.012 [Epub ahead of print]
62. M.M. Colvin, J.L. Cook, P. Chang, G. Francis, D.T. Hsu, M.S. Kiernan, and et al. Antibody-mediated rejection in cardiac transplantation: emerging knowledge in diagnosis and management: a scientific statement from the American Heart Association Circulation. 131 2015 1608 1639
63. E. Roig, L. Almenar, M. Crespo-Leiro, J. Segovia, S. Mirabet, J. Delgado, and et al. Heart transplantation using allografts from older donors: Multicenter study results J Heart Lung Transplant. 34 2015 790 796
64. J.K. Kirklin, D.C. Naftel, F.D. Pagani, R.L. Kormos, L.W. Stevenson, E.D. Blume, and et al. Sixth INTERMACS annual report: a 10,000-patient database J Heart Lung Transplant. 33 2014 555 564
65. I. Lang, S. Gaine, N. Galiè, H.A. Ghofrani, F.O. Le Brun, V. McLaughlin, and et al. Effect of selexipag on long-term outcomes in patients with pulmonary arterial hypertension (PAH) receiving one, two or no PAH therapies at baseline: results from the GRIPHON study Eur Heart J. 36 Abst Suppl 2015 381 382
66. N. Galiè, J.A. Barberà, A.E. Frost, H.A. Ghofrani, M.M. Hoeper, V.V. McLaughlin, and et al. Initial use of ambrisentan plus tadalafil in pulmonary arterial hypertension N Engl J Med. 373 2015 834 844
67. N. Galiè, M. Humbert, J.L. Vachiery, S. Gibbs, I. Lang, A. Torbicki, and et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS); endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT) Eur Heart J. 2015 Aug 29 [Epub ahead of print]. pii: ehv317